1. Home
  2. PLBC vs GOSS Comparison

PLBC vs GOSS Comparison

Compare PLBC & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Plumas Bancorp

PLBC

Plumas Bancorp

HOLD

Current Price

$47.00

Market Cap

316.6M

Sector

Finance

ML Signal

HOLD

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$3.57

Market Cap

726.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLBC
GOSS
Founded
1980
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
316.6M
726.8M
IPO Year
2005
2019

Fundamental Metrics

Financial Performance
Metric
PLBC
GOSS
Price
$47.00
$3.57
Analyst Decision
Buy
Strong Buy
Analyst Count
3
6
Target Price
$55.00
$8.60
AVG Volume (30 Days)
21.5K
3.9M
Earning Date
01-14-2026
11-05-2025
Dividend Yield
2.60%
N/A
EPS Growth
N/A
N/A
EPS
4.23
N/A
Revenue
$89,868,000.00
$44,051,000.00
Revenue This Year
$21.11
N/A
Revenue Next Year
$16.11
$6.41
P/E Ratio
$10.92
N/A
Revenue Growth
12.51
N/A
52 Week Low
$38.71
$0.76
52 Week High
$49.47
$3.87

Technical Indicators

Market Signals
Indicator
PLBC
GOSS
Relative Strength Index (RSI) 64.60 56.81
Support Level $43.50 $3.53
Resistance Level $47.03 $3.87
Average True Range (ATR) 0.79 0.24
MACD 0.20 -0.02
Stochastic Oscillator 77.94 51.96

Price Performance

Historical Comparison
PLBC
GOSS

About PLBC Plumas Bancorp

Plumas Bancorp provides various banking products and services in Northeastern California and Northwestern Nevada. It provides various deposit products such as checking, interest-bearing checking, business sweep, public funds sweep, savings, time deposit, and retirement accounts. The bank's loan portfolio consists of commercial real estate loans; commercial and industrial loans; consumer loans; agricultural loans; residential real estate loans, and construction and land development loans. The bank generates revenue from loans and investment securities in its portfolio and, to a lesser extent, service fees.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: